Profile
ADGM ABT BSX-PA BSX SYK MDT
Company Name Adagio Medical Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $20.00M $223.47B $175.45B $150.72B $129.62B $107.94B
Employees 0.08K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Todd Usen Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
ADGM ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
ADGM ABT BSX-PA BSX SYK MDT
Last Close $1.3 $128.85 $122.18 $101.9 $365.06 $84.16
High 52 $8.17 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.74 $100.07 $122.18 $71.87 $315.94 $76.84
Price vs. 52 Week High -84.09 % -8.11 % 0 % -4.03 % -8.71 % -10.94 %
Price vs. 52 Week Low 75.68 % 28.76 % 0 % 41.78 % 15.55 % 9.53 %
Total Return
ADGM ABT BSX-PA BSX SYK MDT
1 Month Return 39.05 % 1.77 % 0 % -0.43 % -0.74 % -4.61 %
3 Month Return 28.71 % 3.06 % 0 % -0.04 % -7.42 % -6.69 %
6 Month Return -55.17 % 12.81 % 0 % 20.26 % 3.47 % -7.1 %
9 Month Return 0 % 22.43 % 0 % 36.01 % 10.07 % 6.94 %
YTD Return 23.81 % 13.92 % 0 % 14.08 % 1.39 % 5.36 %
1 Year Return 0 % 19.83 % 0 % 39.26 % 8.78 % 5.54 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ADGM ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.77 % - - 0.97 % 3.33 %
Dividend Paid and Capex Coverage Ration (TTM) -41.32 % 1.42 % 3.37 % 3.37 % 2.15 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.62 % 1.24 % 1.13 % 40.73 % 84.62 %
Growth
ADGM ABT BSX-PA BSX SYK MDT
Asset Growth 609.86 % 11.2 % 12.12 % 7.66 % -1.06 %
Gross Profit Growth -65.81 % 5.01 % 16.12 % 10.25 % 3.12 %
Revenue Growth -10.33 % 4.59 % 17.61 % 10.23 % 3.64 %
Revenue 3 Year 31.51 % -0.18 % 36.16 % 30.69 % 8.85 %
Revenue 5 Year - 34.24 % 47.52 % 49.02 % 7.41 %
Revenue 10 Year - 80.43 % 104.22 % 132.01 % 43.65 %
EBIT Growth -123.61 % 5.36 % 11.1 % -5.12 % -6.22 %
Net Income Growth -40.94 % 134.18 % 16.32 % -5.43 % -2.18 %
Net Income 3 Yeari Growth Per Share -981.51 % 94.27 % 72.05 % 48.52 % 3.26 %
Net Income 5 Yeari Growth Per Share -524070.61 % 271.11 % -62.72 % 41.05 % -19.5 %
Net Income 10 Yeari Growth Per Share -524070.61 % 410.99 % 524.58 % 477.35 % -9.48 %
Operating Income Growth -123.61 % 5.36 % 11.1 % -5.12 % -6.22 %
Operating Cash Flow Growth (CFG) 37.67 % 17.86 % 37.24 % 14.31 % 12.39 %
Operating 3 Year CFG -1872.34 % -16.72 % 77.55 % 28.64 % 10.18 %
Operating 5 Year CFG - 42.4 % 76.92 % 90.05 % -1.78 %
Operating 10 Year CFG - 102.79 % 143.61 % 136.49 % 3.3 %
EPS Growth -2212.5 % 134.55 % 16.67 % -5.76 % -2.12 %
EPS Diluted Growth -2212.5 % 134.56 % 16.82 % -5.94 % -2.13 %
Book Value Per Share 143.55 % 23.54 % 11.25 % 10.57 % -2.26 %
Share Holder 3 Year Equity Growth Per Share -81.12 % 36.46 % 26.58 % 37.24 % -1.1 %
Share Holder 5 Year Equity Growth Per Share 194235.1 % 56.53 % 48.35 % 58.15 % 1.66 %
Share Holder 10 Year Equity Growth Per Share 194235.1 % 92.83 % 186.31 % 138.47 % 94.93 %
Dividend Per Share Growth - 8.02 % -100 % 6.63 % 1.54 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % 26.97 % 19.02 %
Dividend 5 Year Growth Per Share - 72.53 % - 53.81 % 38.05 %
Dividend 10 Year Growth Per Share - 148.92 % - 162.12 % 147.94 %
Debt Growth -59.29 % -5.37 % 13.21 % -89.16 % 6.91 %
Free Cash Flow Growth 37.07 % 25.54 % 55.31 % 11.19 % 13.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 26 Apr 2024
Profitability
ADGM ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM -302.45 % 55.59 % 67.02 % 67.15 % 62.84 % 62.89 %
Return on Assets TTM -2.97 % 16.46 % 4.7 % 5.16 % 6.97 % 4.73 %
Return on Equity TTM -10.2 % 32.37 % 8.94 % 9.82 % 15.02 % 8.69 %
Return on Capital Employed TTM -14.55 % 10.32 % 8.63 % 9.32 % 10.75 % 7.74 %
Net Income Per EBT TTM 59.77 % 191.1 % 81.07 % 81.97 % 85.71 % 81.56 %
EBT Per Ebit TTM 36.84 % 101.01 % 80.13 % 80.59 % 91.89 % 86.39 %
EBIT Per Revenue TTM -2947.12 % 16.55 % 17.01 % 17.52 % 16.82 % 18.21 %
Cash Flow To Debt Ratio TTM -114.71 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Receivables Turnover TTM 5.44 4.42 6.55 6.86 5.67 5.43
Payables Turnover TTM 0.45 4.44 5.75 6.01 5 5.39
Inventory Turnover TTM 0.48 3.01 1.97 2.05 1.76 2.2
Fixed Asset Turnover TTM 27.25 % 393.6 % 447.28 % 468.83 % 655.31 % 503.55 %
Asset Turnover TTM 0.46 % 51.53 % 42.51 % 44.56 % 52.58 % 36.9 %
Operating Cash Flow Per Share TTM -1.1 4.94 2.33 2.33 11.13 5.69
Free Cash Flow Per Share TTM -1.13 3.67 1.66 1.65 9.15 4.26
Cash Per Share TTM 194.43 % 460.07 % 28.12 % 28.03 % 1155.38 % 617.75 %
Operating Cash Flow Sales Ratio TTM -3272.17 % 20.4 % 20.51 % 19.57 % 18.77 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.42 % 74.21 % 70.98 % 70.98 % 82.2 % 74.96 %
Cash Flow Coverage Ratios TTM -114.71 % 56.97 % 30.82 % 30.82 % 31.2 % 27.41 %
Price To Free Cash Flows Ratio TTM -1.22 35.19 57.79 61.82 37.17 19.74
Price To Operating Cash Flows Ratio TTM -1.18 26.07 40.82 43.82 30.5 14.8
Price Cash Flow Ratio TTM -1.18 26.07 40.82 43.82 30.5 14.8
Income Statement (TTM)
ADGM ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $-0B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio -620.07% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0.06B $10.83B $2.6B $2.6B $5.72B $8.2B
Net Income $-0.05B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -3.7 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
ADGM ABT BSX-PA BSX SYK MDT
Long Term Debt $0.02B $13.52B $8.97B $8.97B $0B $24.77B
Total Liabilities $0.03B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $0.02B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.75B $8.34B
Total Debt $0.02B $15.02B $10.75B $10.75B $1.41B $26.05B
Total Assets $0.05B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
ADGM ABT BSX-PA BSX SYK MDT
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $-0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0.02B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 128.85
AEMD Aethlon Medical, Inc. 0.3813
AFIB Acutus Medical, Inc. 0.041
AHCO AdaptHealth Corp. 8.41
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 183.35
ALUR Allurion Technologies Inc. 2.4
AMIX Autonomix Medical, Inc. Common Stock 2.08
ANIK Anika Therapeutics, Inc. 14.43
AORT Artivion, Inc. 23.84
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 0.8905
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 11.51
AVNS Avanos Medical, Inc. 12.35
AVR Anteris Technologies Global Corp. Common Stock 4.98
AXDX Accelerate Diagnostics, Inc. 0.5775
AXGN AxoGen, Inc. 16.4
AXNX Axonics, Inc. 70.98
Unlock